Gene therapy offers hope for kids with rare brain disease

This study tests a gene therapy called RGX-121 in children aged 4 months to 5 years with Hunter syndrome, a rare genetic disease that affects the brain and body. The therapy delivers a working copy of the missing gene to the central nervous system. Researchers will measure improvements in thinking, daily living skills, and safety over up to five years.